Manufacturers Life Insurance Company, The Krystal Biotech, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 31,225 shares of KRYS stock, worth $5.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,225
Previous 41,015
23.87%
Holding current value
$5.01 Million
Previous $7.53 Million
24.6%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding KRYS
# of Institutions
310Shares Held
24.3MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$634 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$457 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$421 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$233 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$159 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.12B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...